Discussion
Long-term treatment with Givlaari (givosiran), an approved medication for acute intermittent porphyria (AIP), helped prevent further episodes of AIP in a man in his 20s with severe neurological complications from earlier attacks, according to a case study. The researchers say using the injection medication as a preventive treatment…